Acetaminophen Recruiting Phase 2 Trials for Acute Lymphoblastic Leukaemias (ALL) Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03913559Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia